Home » Topics » BioWorld Science

BioWorld Science
RSS

Interim data presented from phase I study of TK-216 in Ewing's sarcoma

Nov. 15, 2019

FDA grants accelerated approval to Brukinsa for mantle cell lymphoma

Nov. 15, 2019

FDA approves Fetroja for complicated urinary tract infections

Nov. 15, 2019

I-Mab obtains Chinese IND clearance for phase I trials of TJM-2 in rheumatoid arthritis

Nov. 15, 2019

Phase II study of AV-101 in major depressive disorder does not meet primary endpoint

Nov. 15, 2019

Results from SILK cohort evaluating tesevatinib in ADPKD patients presented at Kidney Week

Nov. 15, 2019

New IDO-1 inhibitors identified at Phenex Discovery Verwaltungs

Nov. 15, 2019

Pfizer patents cyclin-dependent kinase inhibitors

Nov. 15, 2019

New mu-opioid receptor agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

Nov. 15, 2019

ViiV Healthcare synthesizes prodrugs of HIV maturation inhibitors

Nov. 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026